Recall D-0113-2026

US Class II Ongoing · initiated 2025-10-10

Recalling firm

QuVa Pharma, Inc., TX

Product

R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50

Reason for recall

Presence of Particulate Matter

← All recalls